AI-guided brain tumor research

Using AI and single-cell genomics to discover better therapies for brain tumors.

The lab develops computational methods and data resources to advance the understanding of brain tumor biology and enable predictive modeling, mechanistic insight, and clinically actionable discovery.

Generative AI models

Predicting cellular responses to perturbations across brain tumor states

Single-cell atlases

Millions of profiles spanning malignant, immune, and neural ecosystems

Therapeutic prioritization

Drug repurposing and target discovery grounded in patient-specific data

Abstract AI and single-cell genomics illustration of a brain tumor research program
  • Generative AI for perturbation and response modeling
  • Single-cell and multimodal genomics of brain tumors
  • Drug repurposing using molecular and chemical structure data
  • Translational models for patient-specific therapeutic hypotheses

Current directions

The lab is focused on computational tools and data resources that can make brain tumor biology more predictive, mechanistic, and clinically actionable.

Perturbation prediction at single-cell resolution

We are building generative AI models trained on millions of single-cell profiles to predict the effects of perturbations across tumor and microenvironmental cell states.

Drug repurposing for brain tumors

We combine large-scale single-cell datasets with chemical structure information to identify therapeutic candidates that can be repurposed for brain tumors.

Lab-built methods and resources

Representative tools from the program include SCRAM, COORS, CLIPPR, CaSpER, and XCVATR, spanning cell annotation, developmental state mapping, subtyping, and RNA-inferred genomic profiling.

Browse methods →

AI-guided therapeutic discovery

Connecting cell states, perturbation models, and drug repurposing.

Our computational framework integrates large-scale single-cell tumor data, predictive AI models, and chemical representations to identify therapies that matter for brain tumors.

Abstract illustration of AI-guided drug discovery for brain tumors
Portrait of Akdes Serin Harmanci

Akdes Serin Harmanci

Assistant Professor, Neurosurgery

Akdes Serin Harmanci leads the Serin Lab at Baylor College of Medicine. The lab develops AI and single-cell genomic methods to study brain tumors, model therapeutic response, and translate molecular complexity into tractable treatment strategies.

Join the lab

We are interested in students, postdocs, and collaborators who want to work on AI, machine learning, single-cell analysis, cancer genomics, and computational neuro-oncology.

If you are reaching out about a position, include your CV, a short summary of your background, and a few sentences about the problems you want to work on.

View contact details